Listed by the USPTO as FLINDERS, JEREMY C
Tech Center 1600 • Art Units: 1636 1639 1644 1675 1682 1684
This examiner grants 64% of resolved cases
FLINDERS, JEREMY C works in Tech Center 1600 and Art Unit 1636. His record includes 613 resolved cases, a 63.5% allowance rate, and a median of 1382 days to allowance. The profile shows allowance in a majority of resolved cases, but prosecution commonly extends beyond three years.
The interview lift is 17.0%, providing a meaningful positive association with allowance outcomes. Practitioners may consider interviews when a focused discussion can distinguish the claims from the cited art. The listed companies are Natera, 10x Genomics, and Yale University. The listed firms are Clark+Elbing, WOLF GREENFIELD & SACKS, and Adams & Reese.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18176062 | CRISPR/Cas9 MULTIPLEX KNOCKOUT OF HOST CELL PROTEINS | Final Rejection | HOFFMANN-LA ROCHE INC. |
| 18015990 | MATERIALS AND METHODS FOR LOCALIZED DETECTION OF NUCLEIC ACIDS IN A TISSUE SAMPLE | Final Rejection | The Regents of the University of Michigan |
| 18580283 | ITERATIVE OLIGONUCLEOTIDE BARCODE EXPANSION FOR LABELING AND LOCALIZING MANY BIOMOLECULES | Non-Final OA | GOOGLE LLC |
| 19463003 | DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS | Final Rejection | Natera, Inc. |
| 19463001 | DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS | Final Rejection | Natera, Inc. |
| 18387669 | SYSTEMS AND METHODS FOR METABOLOME ANALYSIS | Non-Final OA | 10x Genomics, Inc. |
| 18334775 | METHODS OF DETERMINING A SURGICAL MARGIN AND METHODS OF USE THEREOF | Non-Final OA | 10x Genomics, Inc. |
| 18560003 | STRUCTURE BASED ISOLATION OF PMHC-RESTRICTED ANTIBODIES | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17684289 | METHODS AND COMPOSITIONS FOR WHOLE TRANSCRIPTOME AMPLIFICATION | Non-Final OA | Becton, Dickinson and Company |
| 17881387 | ASSAY COMPOUND SCREENING | Final Rejection | University of Connecticut |
| 18323356 | MULTIPLEX DETECTION OF INTRACELLULAR OR SURFACE MOLECULAR TARGETS IN SINGLE CELLS | Non-Final OA | Yale University |
| 17764804 | DETERMINISTIC BARCODING FOR SPATIAL OMICS SEQUENCING | Final Rejection | Yale University |
| 17695073 | STRUCTURED SUBSTRATES FOR OPTICAL SURFACE PROFILING | Non-Final OA | TRUSTEES OF BOSTON UNIVERSITY |
| 18151128 | Beads as Transposome Carriers | Non-Final OA | Illumina, Inc. |
| 17864655 | PRE-TEMPLATED INSTANT PARTITIONING OF DNA-ENCODED LIBRARIES | Non-Final OA | ILLUMINA, INC. |
| 18451792 | METHODS AND ALGORITHMS FOR AIDING IN THE DETECTION OF CANCER | Non-Final OA | 20/20 GeneSystems |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy63.5% of resolved applications examined by Jeremy C Flinders were allowed (613 resolved cases), compared with 37.1% across Art Unit 1636 over the last five years.
This examiner's interview lift is +17.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Jeremy C Flinders took 1,382 days on average from filing to allowance.
Jeremy C Flinders examines applications in Art Unit 1636 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
